The Food and Drugs Authority (FDA) says it has not registered any Rapid Diagnostic Test kits (RDT) to be used for testing and diagnosis of the Coronavirus disease (COVID-19) in Ghana.
In a statement signed and issued on Tuesday [march 24, 2020] by the Chief Executive of the FDA, Mrs Delese A.A. Darko, the FDA said the only way of testing for the virus in Ghana and approved by the Ministry of Health (MoH) is the Polymerase Chain Reaction (PCR) tests.
The statement added that the FDA is not registering any RDTs for self tests, saying any updates would be communicated to the general public.
The FDA has therefore urged the public to abide by the President’s preventive measures to help curb the spread of the disease.
Ghana as of Monday night [March 23, 2020] recorded 27 confirmed cases of the disease with 2 deaths.
Below is a copy of the FDA’s statement;